Ambu A/S (OTCMKTS:AMBBY) Shares Up 13.4% – Time to Buy?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY)’s stock price shot up 13.4% on Wednesday. The stock traded as high as $13.20 and last traded at $13.20. Approximately 101 shares changed hands during mid-day trading, a decline of 85% from the average daily volume of 655 shares. The stock had previously closed at $11.64.

Analyst Ratings Changes

Separately, UBS Group cut Ambu A/S from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 15th. One research analyst has rated the stock with a Hold rating. According to data from MarketBeat.com, Ambu A/S presently has an average rating of “Hold”.

Ambu A/S Stock Performance

The company has a quick ratio of 1.69, a current ratio of 2.77 and a debt-to-equity ratio of 0.08. The stock has a market cap of $3.05 billion, a price-to-earnings ratio of 43.33 and a beta of 0.86. The stock’s fifty day moving average is $11.10 and its 200-day moving average is $10.99.

Ambu A/S (OTCMKTS:AMBBY) last posted its earnings results on Thursday, November 5th. The company reported $0.14 earnings per share for the quarter. Ambu A/S had a net margin of 8.18% and a return on equity of 8.49%.

Ambu A/S Company Profile

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. Its products are designed to support clinical procedures while reducing the need for cleaning, disinfection and reprocessing associated with reusable equipment.

The company’s portfolio includes single-use endoscopy systems, such as the aScope range of flexible endoscopes and related visualization equipment, as well as products for anesthesia, airway management, ventilation, resuscitation and patient monitoring.